PSORIASISPoster 49Effisayil ON, an Open-Label, Long-Term Extension Study of Spesolimab Treatment in Patients with Generalized Pustular Psoriasis: Interim...
PSORIASISPoster 50Spesolimab for the Prevention of Generalized Pustular Psoriasis (GPP) Flares: Results from the Randomized, Placebo-Controlled Trial...
PSORIASISPoster 51Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis: Evaluation of...